Search Results
Jan 26, 2026, 14:12 ET KIA ANUNCIA EL PRECIO DEL NIRO EV DEL 2026
otros países. Apple CarPlay® funciona con el servicio de datos móviles de su smartphone. Pueden aplicarse tarifas de datos normales.[iii] La interfaz de usuario del vehículo es un producto de Google, y se aplican sus términos y condiciones de uso. Requiere la aplicación Android Auto
More news about: Kia America
Jan 26, 2026, 12:55 ET French Connection Group and G-III Apparel Group Announce Licensing Agreement for the North American Market
Jan. 26, 2026 /PRNewswire/ -- French Connection Group (FCG) today announces a long-term partnership with G-III Apparel Group (G-III), a global expert in fashion, to develop and distribute men's and women's apparel and selected accessory products across North America. Effective
More news about: French Connection
Jan 26, 2026, 11:07 ET South Atlantic Bancshares, Inc. Names Jason Caskey to Board of Directors
conditions, and any regulatory responses thereto; (ii) slower economic growth rates or potential recession in the United States and our market areas; (iii) uncertainty or perceived instability in the banking industry as a whole; (iv) increased competition for deposits among traditional and nontraditional
More news about: South Atlantic Bank
Jan 26, 2026, 10:12 ET The Republic of Ecuador Announces Amounts Tendered as of Expiration of Cash Tender Offer for Certain Series of its Notes
or prior to the Settlement Date) valid Tenders pursuant to the Offer and, if so accepted, (ii) the Maximum Aggregate Purchase Price for each series, (iii) the Tendered Aggregate Purchase Price for each series, (iv) the aggregate principal amount of Tenders of each series of the Notes that have been accepted,
More news about: The Republic of Ecuador
Jan 26, 2026, 09:30 ET StemCyte Announces FDA Clearance of Expanded Access Program for RegeneCyte® (HPC, Cord Blood) to Address Unmet Need in Long COVID
providing a vital pathway for patients who are severely impacted by the syndrome but may not meet the specific enrollment criteria for ongoing Phase III multi-center trials."The FDA's clearance of this program is a significant validation of the safety and therapeutic potential of RegeneCyte®,
More news about: StemCyte
Jan 26, 2026, 09:26 ET Notice of Pendency and Proposed Settlement of Stockholder Class Action Involving All Record and Beneficial Holders of HighCape Capital Acquisition Corp. Class A Common Stock Between May 10, 2021 and June 10, 2021
should be finally appointed as Class Representative for the Class and Plaintiff's Counsel should be finally appointed as Class Counsel for the Class; (iii) whether the proposed Settlement should be approved as fair, reasonable, and adequate to Plaintiff and the other members of the Class and in their best
More news about: JND Legal Administration
Jan 26, 2026, 09:00 ET Glancy Prongay & Murray LLP Announces Proposed Settlement on Behalf of Purchasers of Hub Cyber Security Ltd. Publicly Traded Common Stock - HUBC
1:23-CV-05764-ASSUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION, CERTIFICATION OF SETTLEMENT CLASS, AND PROPOSED SETTLEMENT; (II) SETTLEMENT FAIRNESS HEARING; AND (III) MOTION FOR AN AWARD OF ATTORNEYS' FEES AND REIMBURSEMENT OF LITIGATION EXPENSESTO: All persons and entities that purchased or otherwise
More news about: Glancy Prongay & Murray LLP
Jan 26, 2026, 09:00 ET KIA ANNOUNCES PRICING FOR 2026 NIRO EV
Inc., registered in the U.S. and other countries. Apple CarPlay® runs on your smartphone cellular data service. Normal data rates may apply. [iii] Vehicle user interface is a product of Google, and its terms and privacy statements apply. Requires the Android Auto app on Google Play store and
More news about: Kia America
Jan 26, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.243 Million Tokens, and Total Crypto and Total Cash Holdings of $12.8 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: BitMine Immersion Technologies, Inc.
Jan 26, 2026, 08:00 ET Republic of Trinidad and Tobago Announces Results of Cash Tender Offer
THE "ORDER"), (II) ARE PERSONS FALLING WITHIN ARTICLE 49(2)(A) TO (D) ("HIGH NET WORTH COMPANIES, UNINCORPORATED ASSOCIATIONS ETC.") OF THE ORDER, (III) ARE PERSONS FALLING WITHIN ARTICLE 43 OF THE ORDER, (IV) ARE OUTSIDE THE UNITED KINGDOM, OR (V) ARE PERSONS TO WHOM AN INVITATION OR INDUCEMENT TO ENGAGE
More news about: The Republic of Trinidad and Tobago
Jan 26, 2026, 07:10 ET INVESTOR DEADLINE: Fermi Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
campus; (ii) the extent to which Project Matador would rely on a single tenant's funding commitment to finance the construction of Project Matador; and (iii) that there was a significant risk that the tenant would terminate its funding commitment.The Fermi class action lawsuit further alleges
More news about: Robbins Geller Rudman & Dowd LLP
Jan 26, 2026, 02:00 ET HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
development and manufacturing solutions. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing.WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously
More news about: HanchorBio Inc.
Jan 25, 2026, 19:10 ET Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
The gastrointestinal tolerability of ASC30 titrated weekly was comparable to published results of orforglipron titrated every four weeks in the Phase III ATTAIN-1 study. The total treatment discontinuation rate due to adverse events for the ASC30 Phase II study for obesity or overweight was 4.8%.ASC30
More news about: Ascletis Pharma Inc.
Jan 24, 2026, 05:30 ET Best Collagen Supplements (2026): California Gold Nutrition Named Top Collagen Choice by Expert Consumers
multiple collagen sources and functional combinations.Key product categories include:Hydrolyzed Collagen Type I & III products offered in powder and tablet form, commonly associated with skin, hair, nails, and connective tissue supportMarine collagen peptides,
More news about: ExpertConsumers.org
Jan 23, 2026, 22:56 ET Coupang Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Coupang, Inc. - CPNG
information for nearly six months without being detected; (ii) this subjected the Company to a materially heightened risk of regulatory and legal scrutiny; (iii) when defendants became aware that the Company had been subjected to this data breach, they did not report it in a current report filing in compliance
More news about: ClaimsFiler
Jan 23, 2026, 22:54 ET CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. - CRWV
severity of the risk that its reliance on a single third-party data center supplier created for its ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue; and (iv) as a result, CoreWeave's public statements
More news about: ClaimsFiler
Jan 23, 2026, 19:36 ET CoreWeave, Inc. Investors Who Lost Money Investing in CRWV Should Contact Robbins LLP for Information About Their Rights
that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; and (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue.A series of disclosures revealing the truth resulted
More news about: Robbins LLP
Jan 23, 2026, 19:19 ET KELLAN A. WARREN, MELISSA L. WARREN, AND THE KELLAN CODY WARREN GS-TRUST TO AUCTION 10,000 SHARES OF COMMON STOCK OF KELLAN, INC., VIA PUBLIC SALE
or other evidence acceptable to Secured Party that will show the financial ability of the Potential Bidder to purchase the Public Sale Collateral, (iii) a completed and executed Stock Purchase Agreement in the form provided by Secured Party, and (iv) a deposit in an amount equal to ten percent (10%)
More news about: The Kellan Cody Warren GS-Trust, Kellan A. Warren, and Melissa L. Warren
Jan 23, 2026, 17:05 ET NUVISTA AND OVINTIV ANNOUNCE NUVISTA SHAREHOLDER APPROVAL AND RECEIPT OF FINAL ORDER FOR TRANSACTION WITH OVINTIV AND PRELIMINARY RESULTS OF ELECTIONS BY NUVISTA SHAREHOLDERS REGARDING FORM OF CONSIDERATION
Consideration"); (ii) 0.344 of a share in the common stock of Ovintiv (each whole share, an "Ovintiv Share") per NuVista Share (the "Share Consideration"); or (iii) a combination of Cash Consideration and Share Consideration for their NuVista Shares, subject to rounding and proration based on a maximum aggregate
More news about: Ovintiv Inc.
Jan 23, 2026, 16:05 ET NaaS Technology Inc. Announces Results of Extraordinary General Meeting on January 23, 2026
registration of the solvency statement made under section 14A and the minute as required by the Companies Act (as revised) of the Cayman Islands, and (iii) an ordinary resolution to authorize the Company's directors, officers and agents to carry out the foregoing. The Meeting Notice had been furnished on
More news about: NaaS Technology Inc.
Jan 23, 2026, 14:05 ET Ultragenyx Stock Declines After Missing Primary Endpoints on its Phase III Orbit and Cosmic Studies
Korsinsky, LLP is investigating Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE) following the Company's announcement of topline results from its Phase III Orbit and Cosmic Studies, focusing on the effectiveness of setrusumab (UX143) on Osteogenesis Imperfecta.
More news about: Levi & Korsinsky, LLP
Jan 23, 2026, 13:43 ET INVESTOR DEADLINE: CoreWeave, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; and (iii) the foregoing was reasonably likely to have a material negative impact on CoreWeave's revenue.The CoreWeave class action lawsuit alleges
More news about: Robbins Geller Rudman & Dowd LLP
Jan 23, 2026, 12:22 ET Brazil Achieves a Historic Milestone: Blau Farmacêutica Fully Develops One of the World's Most Advanced Biosimilars Immunotherapies
efficacy.During the Scientific advice EMA has indicated that, contingent on robust quality and Phase I data, a waiver of Phase III clinical trials may be possible, significantly accelerating patient access — a regulatory pathway consistent with leading global biosimilar programs.
More news about: Blau Farmacêutica
Jan 23, 2026, 12:00 ET Denvix Shines at CES 2026 with Jimmy Butler Appearance and New Product Launch
technology, Denvix delivers solutions that meet the needs of modern consumers and sets new industry standards.In 2025, Denvix signed Jimmy Butler III as the global brand ambassador and became the official global partner of the Golden State Warriors. Denvix also expanded its presence in motorsports
More news about: Denvix
Jan 23, 2026, 09:12 ET Latch (Now DOOR) Files Q2 2025 SEC Report and Provides Q2 2025 Financial Update
net loss, excluding the impact of the following items, if applicable: (i) depreciation and amortization expense, (ii) net interest income or expense, (iii) provision for income taxes, (iv) change in fair value of warrant liability, trading securities, or derivative instruments, (v) restructuring costs,
More news about: DOOR